Correlation Between Vericel Corp and OnKure Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Vericel Corp and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vericel Corp Ord and OnKure Therapeutics,, you can compare the effects of market volatilities on Vericel Corp and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and OnKure Therapeutics,.

Diversification Opportunities for Vericel Corp and OnKure Therapeutics,

-0.67

Correlation Coefficient

Vericel Corp  OnKure Therapeutics,

Excellent diversification

The 3 months correlation between Vericel and OnKure is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Vericel Corp i.e., Vericel Corp and OnKure Therapeutics, go up and down completely randomly.

Pair Corralation between Vericel Corp and OnKure Therapeutics,

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.72 times more return on investment than OnKure Therapeutics,. However, Vericel Corp Ord is 1.38 times less risky than OnKure Therapeutics,. It trades about 0.06 of its potential returns per unit of risk. OnKure Therapeutics, is currently generating about -0.1 per unit of risk. If you would invest  4,694  in Vericel Corp Ord on October 4, 2024 and sell it today you would earn a total of  797.00  from holding Vericel Corp Ord or generate 16.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vericel Corp Ord  vs.  OnKure Therapeutics,

Vericel Corp Ord

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point.

OnKure Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Vericel Corp and OnKure Therapeutics,

The main advantage of trading using opposite Vericel Corp and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.

The idea behind Vericel Corp Ord and OnKure Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.